Elham Baghbani
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer
- RNA Interference and Gene Delivery
Papers in
-
- Circular RNAs in diseases 14
- RNA Interference and Gene Delivery 7
- RNA modifications and cancer 5
-
- MicroRNA in disease regulation 23
- Cancer-related molecular mechanisms research 10
- Co-authors
- Behzad Baradaran (39 shared papers)Saeed Noorolyai (17 shared papers)Sanam Sadreddini (2 shared papers)Neda Shajari (1 shared paper)Behzad Mansoori (16 shared papers)Vahid Khaze (17 shared papers)Ali Mohammadi (12 shared papers)Dariush Shanehbandi (16 shared papers)
In The Last Decade
Elham Baghbani
54 papers receiving 1.2k citations
Elham Baghbani's Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 397
- Molecular Biology 650
- Oncology 231
- Immunology 155
- Physiology 33
Countries citing papers authored by Elham Baghbani
This map shows the geographic impact of Elham Baghbani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Baghbani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Baghbani more than expected).
Fields of papers citing papers by Elham Baghbani
This network shows the impact of papers produced by Elham Baghbani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Baghbani. The network helps show where Elham Baghbani may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Baghbani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The relation between PI3K/AKT signalling pathway and cancer Hit paper breakdown → | 2019 | 477 |
| 2 | 2021 | 42 | |
| 3 | 2019 | 41 | |
| 4 | 2018 | 39 | |
| 5 | 2019 | 38 | |
| 6 | 2021 | 37 | |
| 7 | 2021 | 36 | |
| 8 | siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells. | 2015 | 36 |
| 9 | 2016 | 35 | |
| 10 | 2019 | 35 | |
| 11 | 2018 | 28 | |
| 12 | 2021 | 27 | |
| 13 | 2018 | 24 | |
| 14 | Effects of Urtica dioica dichloromethane extract on cell apoptosis and related gene expression in human breast cancer cell line (MDA-MB-468). | 2016 | 24 |
| 15 | 2016 | 23 | |
| 16 | 2019 | 22 | |
| 17 | 2018 | 21 | |
| 18 | 2016 | 21 | |
| 19 | 2018 | 19 | |
| 20 | 2019 | 16 |
About Elham Baghbani
Elham Baghbani is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Pathology and Forensic Medicine, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Circular RNAs in diseases (14 papers), Cancer-related molecular mechanisms research (10 papers), RNA Interference and Gene Delivery (7 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (397 citations), Molecular Biology (650 citations), Oncology (231 citations), Immunology (155 citations) and Physiology (33 citations). Elham Baghbani has collaborated with scholars based in Iran, Italy and Denmark. Frequent co-authors include Behzad Baradaran, Saeed Noorolyai, Sanam Sadreddini, Neda Shajari, Behzad Mansoori, Vahid Khaze, Ali Mohammadi, Dariush Shanehbandi, Ahad Mokhtarzadeh and Amir Baghbanzadeh. Their work appears in journals such as Advanced Pharmaceutical Bulletin, Gene, Biomedicine & Pharmacotherapy, Journal of Cellular Biochemistry and Human Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.